CIK: 0001668343
Total reported value
$13.9M
Reporting period: 2026-03-31 · Number of holdings: 2
DCVC Opportunity Fund II GP, LLC disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $13.9M and a quarterly turnover rate of 35.1%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "D"
DCVC Opportunity Fund II GP, LLC's disclosed holdings carry a Herfindahl concentration index of 0.781 — mathematically equivalent to about 1 equally-sized positions, well below its 2 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 1.06), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
Recent activity leans toward adding more aggressively to already-large existing positions than to newly initiated ones (a 2.6 percentage-point tilt) — a pattern consistent with a momentum-following approach.
Trim RXRX
0.0% -$4.0M
Add IONQ
+532.6% $1.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 87.48% | -9.94% | — | |
| 2 | IONQ | Ionq INC | Stock-Tech | 12.52% | +9.94% | +532.56% |
Performance for Q3 2026
-14.9%
Performance Last 4 Quarters
-42.6%
Based on 87% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 2 | $13.9M | 35 | |
| 2025-12-31 | 2 | $16.6M | 20 | |
| 2025-09-30 | 1 | $19.3M | 92 | |
| 2025-06-30 | 2 | $115.3M | 0 | |
| 2025-03-31 | 2 | $81.5M | 0 | |
| 2024-12-31 | 2 | $113.0M | 0 | |
| 2024-09-30 | 3 | $97.4M | 0 | |
| 2024-06-30 | 3 | $65.9M | 0 | |
| 2024-03-31 | 3 | $71.4M | 0 | |
| 2023-12-31 | 4 | $80.9M | 0 | |
| 2022-09-30 | 5 | $77.3M | 0 | |
| 2022-06-30 | 5 | $68.0M | 0 | |
| 2022-03-31 | 3 | $89.7M | 0 | |
| 2021-12-31 | 4 | $199.5M | 0 |
DCVC Opportunity Fund II GP, LLC's most significant position changes for 2026-03-31: Add: Ionq INC (IONQ) — shares +532.56%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IONQ | Ionq INC | +9.9% | +532.56% | Add |
| 2 | RXRX | Recursion Pharmaceuticals-a | -9.9% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-11-14 | Amendment | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001442276
Total reported value
$13.9M
41 stks
2019-12-31
Stale — no recent filing
AUM within 0.4% of this institution
CIK 0001731031
Total reported value
$13.8M
1 stks
2023-09-30
Stale — no recent filing
AUM within 0.6% of this institution
CIK 0001654913
Total reported value
$13.7M
5 stks
2018-09-30
Stale — no recent filing
AUM within 1.0% of this institution
Institutions with overlapping top holdings
CIK 0001081698
Total reported value
$358.8M
265 stks
2026-03-31
1 of the top 5 holdings overlap, including Ionq INC
CIK 0001503556
Total reported value
$60.1M
3 stks
2023-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Recursion Pharmaceuticals-a
CIK 0001525907
Total reported value
$2.6B
14 stks
2026-03-31
1 of the top 5 holdings overlap, including Ionq INC